Viewing Study NCT05781633


Ignite Creation Date: 2025-12-25 @ 2:42 AM
Ignite Modification Date: 2026-07-02 @ 8:02 AM
Study NCT ID: NCT05781633
Status: UNKNOWN
Last Update Posted: 2023-03-23
First Post: 2023-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mammary Neoplasms, Human View
Keywords: